Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection

Giuseppe Vizzielli, Carmine Conte, Massimo Romano, Anna Fagotti, Barbara Costantini, Claudio Lodoli, Salvatore Gueli Alletti, Khaled Gaballah, Fabio Pacelli, Alfredo Ercoli, Giovanni Scambia, Valerio Gallotta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.

Original languageEnglish
Pages (from-to)359-364
Number of pages6
JournalIn Vivo
Volume32
Issue number2
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Alligators and Crocodiles
Ovarian Neoplasms
Surgery
Dissection
Equipment and Supplies
Seals
Ligation
Urinary Bladder
Tissue
Intraoperative Complications
Observational Studies

Keywords

  • Caiman®
  • Energy device
  • Ovarian cancer
  • Surgery

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection. / Vizzielli, Giuseppe; Conte, Carmine; Romano, Massimo; Fagotti, Anna; Costantini, Barbara; Lodoli, Claudio; Alletti, Salvatore Gueli; Gaballah, Khaled; Pacelli, Fabio; Ercoli, Alfredo; Scambia, Giovanni; Gallotta, Valerio.

In: In Vivo, Vol. 32, No. 2, 01.03.2018, p. 359-364.

Research output: Contribution to journalArticle

@article{df30e4b948bb4435a08662c6509e9567,
title = "Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection",
abstract = "Aim: To evaluate the clinical impact of the use of the Caiman{\circledR} articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman{\circledR} device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman{\circledR} was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman{\circledR} application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman{\circledR} were noted. Conclusion: Caiman{\circledR} can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.",
keywords = "Caiman{\circledR}, Energy device, Ovarian cancer, Surgery",
author = "Giuseppe Vizzielli and Carmine Conte and Massimo Romano and Anna Fagotti and Barbara Costantini and Claudio Lodoli and Alletti, {Salvatore Gueli} and Khaled Gaballah and Fabio Pacelli and Alfredo Ercoli and Giovanni Scambia and Valerio Gallotta",
year = "2018",
month = "3",
day = "1",
doi = "10.21873/invivo.11246",
language = "English",
volume = "32",
pages = "359--364",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection

AU - Vizzielli, Giuseppe

AU - Conte, Carmine

AU - Romano, Massimo

AU - Fagotti, Anna

AU - Costantini, Barbara

AU - Lodoli, Claudio

AU - Alletti, Salvatore Gueli

AU - Gaballah, Khaled

AU - Pacelli, Fabio

AU - Ercoli, Alfredo

AU - Scambia, Giovanni

AU - Gallotta, Valerio

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.

AB - Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.

KW - Caiman®

KW - Energy device

KW - Ovarian cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85045736798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045736798&partnerID=8YFLogxK

U2 - 10.21873/invivo.11246

DO - 10.21873/invivo.11246

M3 - Article

C2 - 29475921

AN - SCOPUS:85045736798

VL - 32

SP - 359

EP - 364

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -